Q Fever News and Research

RSS

Nature News examines controversy surrounding Indian HPV vaccine trial

After four teenage girls involved in a clinical trial in India testing vaccines for human papillomavirus (HPV) died last year, the study "threatens to have a dual legacy: inflaming unfounded fears about a lifesaving vaccine and raising new questions about the management of medical research in the country," Nature News reports.

24 Jun 2011

Copenhagen chemist reveals mechanism behind deadly infections

Anthrax, septicemia and meningitis are some of the planet's most deadly infections. In part because doctors lack basic insights to prevent and cure diseases caused by so called Gram-positive bacteria. Now, a chemist from the University of Copenhagen has revealed the mechanism behind these deadly infections.

24 Jun 2011

Some drug mixtures may be fatal for elderly: study

British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people’s health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.

23 Jun 2011

HKU releases draft genome sequence of scarlet fever strain

Scarlet fever has revealed unusual high infect rate in Hong Kong this year. So far, 466 children were infected and 2 of them dead. Scarlet fever is caused by Streptococcus pyogenes, a gram-positive pathogen that can be transmitted via skin wound and airborne droplet.

23 Jun 2011

Mothers receiving influenza vaccination during pregnancy also protect infants

Infants born to mothers who received the influenza (flu) vaccine while pregnant are nearly 50 percent less likely to be hospitalized for the flu than infants born to mothers who did not receive the vaccine while pregnant, according to a new collaborative study by researchers at Wake Forest Baptist Medical Center and colleagues.

23 Jun 2011

Tips for protecting your skin from sun's harmful rays

Summer is here and for many that means enjoying more outdoor activities. While it's important to remember sun safety, from time-to-time sunburns are bound to happen. Covenant Health System would like to promote sun safety and offer some useful remedies for dealing with sunburns.

22 Jun 2011

WHO special issue addresses economic burden of dengue in the Americas, Africa and Asia

The ten studies in this special issue document the substantial and growing burden of dengue in the Americas, Africa and Asia, and the burden of a chikungunya outbreak in India.

18 Jun 2011

Queen's University installs new pollen trap to control hay fever in Northern Ireland

Local hay fever sufferers will breathe more easily following the news that Northern Ireland's only air pollen sampler has been installed at Queen's University Belfast in association with the Met Office.

16 Jun 2011

Viewpoints: Romney and 'Obamneycare'; 'fundamental constitutional flaws'; leading vs. following in Md.

Hence the young campaign's most unfortunate new coinage, courtesy of Tim Pawlenty: "Obamneycare." That's the word Pawlenty used Sunday to describe President Obama's health-care law, which borrowed ideas from the reform package Romney devised and implemented when he was governor of Massachusetts. Obamacare plus Romneycare equals . . . Okay, we get it, we get it.

15 Jun 2011

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.

14 Jun 2011

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc., announced today that data on ADCETRIS (brentuximab vedotin) in relapsed or refractory Hodgkin lymphoma patients were featured in an oral presentation at the 16th Congress of the European Hematology Association (EHA) in London.

13 Jun 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.

13 Jun 2011

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy.

10 Jun 2011

NIH awards $1.9M grant to Scripps Research scientist for malaria study

A scientist from The Scripps Research Institute has won a four-year, $1.9 million grant from the National Institutes of Health to better understand the parasite that causes malaria, laying the groundwork to develop better drugs to combat the widespread and deadly disease.

10 Jun 2011

Drop in flu vaccination rates alarms health authorities

According to latest figures the number of young children vaccinated against the flu in WA this year has plummeted almost 80 per cent. This is concerning for health officials who believe that parents have been scared off by last year's spate of seizures after the jabs.

8 Jun 2011

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.

7 Jun 2011

Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.

7 Jun 2011

Q Fever News and Research

Nature News examines controversy surrounding Indian HPV vaccine trial

Copenhagen chemist reveals mechanism behind deadly infections

Some drug mixtures may be fatal for elderly: study

HKU releases draft genome sequence of scarlet fever strain

Mothers receiving influenza vaccination during pregnancy also protect infants

Tips for protecting your skin from sun's harmful rays

WHO special issue addresses economic burden of dengue in the Americas, Africa and Asia

Queen's University installs new pollen trap to control hay fever in Northern Ireland

Viewpoints: Romney and 'Obamneycare'; 'fundamental constitutional flaws'; leading vs. following in Md.

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

NIH awards $1.9M grant to Scripps Research scientist for malaria study

Drop in flu vaccination rates alarms health authorities

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011

ITI receives FDA clearance for new Q fever assay kit

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News